日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deep-Learning Tool ScVital Enables Species-Agnostic Integration of Cancer Cell States

深度学习工具 ScVital 实现了与物种无关的癌细胞状态整合

Rub, Jonathan; Chan, Jason E; Sussman, Carleigh; Guzman, Gary; Tap, William D; Antonescu, Cristina R; Singer, Samuel; Tammela, Tuomas; Betel, Doron

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in Sarcoma

循环T细胞和肿瘤微环境特征与肉瘤免疫检查点阻断疗效的相关性

Rosenbaum, Evan; Ehrich, Fiona; Yosofvand, Mohammad; Bradic, Martina; Lee, Jasme; Adamow, Mathew; Movva, Sujana; Kelly, Ciara M; Avutu, Viswatej; Banks, Lauren B; Chan, Jason E; Chi, Ping; Dickson, Mark A; Gounder, Mrinal M; Keohan, Mary L; Maki, Robert G; Reed, Damon R; Fuentes, Paige; Collins, Paige; Desir, Rhoena; Reiner, Allison; Baranov, Oleg; Chernyshov, Konstantin; Kotlov, Nikita; Subramanian, Ajay; Moding, Everett J; Qin, Li-Xuan; Wong, Phillip; Tap, William D; Antonescu, Cristina R; Panageas, Katherine S; Shen, Ronglai; D'Angelo, Sandra P

Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma

帕博西尼治疗晚期高分化/去分化脂肪肉瘤患者的开放标签 II 期试验的总生存期

Babatunde, O O; Seier, K; Schwartz, G; Keohan, M L; D'Angelo, S P; Gounder, M M; Chi, P; Antonescu, C R; Landa, J; Qin, L-X; Crago, A M; Singer, S; Koff, A; Tap, W D; Dickson, M A

Statin use does not impair muscle health in older adults: findings from the SCOPE study

SCOPE 研究发现,他汀类药物的使用不会损害老年人的肌肉健康。

Fazel, Seyedeh Dalia; Tap, Lisanne; Fabbietti, Paolo; Corsonello, Andrea; Kob, Robert; Sieber, Cornel C; Roller-Wirnsberger, Regina; Wirnsberger, Gerhard; Ben-Romano, Ronit; Melzer, Itshak; Kostka, Tomasz; Guligowska, Agnieszka; Carlsson, Axel C; Formiga, Francesc; Moreno-González, Rafael; Ärnlöv, Johan; Lattanzio, Fabrizia; Mattace-Raso, Francesco

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma

CDK4/6 和 PD-1 序贯抑制后肿瘤和免疫动力学:一项去分化脂肪肉瘤 II 期研究的结果

Rosenbaum, Evan; Gularte-Mérida, Rodrigo; Seffar, Evan; Lee, Jasme; Adamow, Mathew; Bradic, Martina; Dickson, Mark A; Avutu, Viswatej; Banks, Lauren B; Chan, Jason E; Chi, Ping; Gounder, Mrinal M; Kelly, Ciara M; Keohan, Mary Louise; Maki, Robert G; Movva, Sujana; Reed, Damon R; Desir, Rhoena; Biniakewitz, Matthew; Erinjeri, Joseph P; Lefkowitz, Robert A; Wong, Phillip; Antonescu, Cristina R; Qin, Li-Xuan; Panageas, Katherine S; Shen, Ronglai; Singer, Samuel; Koff, Andrew; Tap, William D; D'Angelo, Sandra P

Mixed-Methods to Define Meaningful Change using Exit Interviewand Clinical Trial Data in Patients with Tenosynovial Giant Cell Tumor (TGCT)

采用混合方法,利用离院访谈和临床试验数据来定义腱鞘巨细胞瘤(TGCT)患者的有意义变化

Gelhorn, Heather L; Cutts, Katelyn N; Harrow, Brooke; Tait, Christopher; Saunders, Amanda; Fikre, Tsion; Han, Yipin; Zeringo, Nicholas A; Van De Sande, Michiel; Tap, William; Gelderblom, Hans; Bernthal, Nicholas

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma

rucaparib 和 nivolumab 治疗平滑肌肉瘤患者的 II 期研究

Sujana Movva ,Kenneth Seier ,Martina Bradic ,Karmelina Charalambous ,Evan Rosenbaum ,Ciara M Kelly ,Seth M Cohen ,Martee L Hensley ,Viswatej Avutu ,Lauren B Banks ,Jason E Chan ,Ping Chi ,Sandra D'Angelo ,Mark A Dickson ,Mrinal M Gounder ,Mary L Keohan ,Robert G Maki ,Angela Green ,Vicky Makker ,Maria M Rubinstein ,Sara Saunds ,Jae-Mun Cho ,Robert A Lefkowitz ,Joseph Erinjeri ,Li-Xuan Qin ,Ronak Shah ,Phillip Wong ,William Tap

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma

突变型IDH1抑制剂Ivosidenib的I期研究:在常规软骨肉瘤患者中的长期安全性和临床活性

Tap, William D; Cote, Gregory M; Burris, Howard; Gore, Lia; Elias, Anthony; Beeram, Murali; Conley, Anthony P; Gianolio, Diego A; Qu, Zhe; Pandya, Susan; Trent, Jonathan C

Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases

细胞凋亡诱导因子(AIF)处于细胞存活和细胞死亡的十字路口:对癌症和线粒体疾病的启示

Nguyen, Tran Ngoc Anh; Lai, Hong-Toan; Fernandes, Romain; Dall'Olio, Filippo G; Blériot, Camille; Ha-Duong, Tap; Brenner, Catherine

A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma

一项针对晚期肉瘤患者的 I 期研究,评估 CSF1R 抑制剂 vimseltinib 与 PD-L1 抑制剂 avelumab 联合用药的疗效。

E Rosenbaum ,K Seier ,M Bradic ,S Movva ,C M Kelly ,M A Dickson ,M L Keohan ,M M Gounder ,P Chi ,B A Nacev ,J E Chan ,V Avutu ,M Biniakewitz ,S Jasnani ,M Duchemin ,R Desir ,P Wong ,J Erinjeri ,S Hwang ,C R Antonescu ,L-X Qin ,W D Tap ,S P D'Angelo